Breast Cancer
Breast cancer treated by butyroyloxymethyl-diethyl phosphate and doxorubicin
Published in Cancer Weekly, November 14th, 2006
Researchers in Israel conducted a study "to investigate the anticancer activity and mode of action of AN-7, a prodrug of butyric acid and formaldehyde, as a single agent and in combination with doxorubicin in human carcinoma MCF-7 and the multidrug resistant MCF-7 Dx cell lines. The anti-cancer activity of AN-7 as a single agent or in combination with doxorubicin was measured by the Hoechst cell viability and colony forming assays as well as by FACS analyses of cells stained with propidium iodide and annexin V-FITC."
"Modulations of protein expression...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-11-14)
More Articles from Cancer Weekly
- Apoptosis
Ewing sarcoma cell apoptosis induced by arsenic trioxide - Diet & Nutrition
Benign prostatic hyperplasia risk reduced with intake of selected micronutrients - Diet & Nutrition
Cancer survival might depend on season of diagnosis and sunlight exposure - Drug Development
Randomized approaches might decrease high failure rate for oncological drugs in phase III trials - Cancer Gene Therapy
Dankook University, Institute of Nanosensor and Biotechnology details research in cancer gene therapy - Cancer Gene Therapy
Data on cancer gene therapy detailed by investigators at Aichi Cancer Center Research Institute, Division of Virology - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
